Overview

Gender

male

Dipal Doshi was formerly the Chief Business Officer of Amicus Therapeutics, where he oversaw the company's business and corporate growth, global strategy, new product planning, and commercial planning operations. Mr. Doshi was formerly the Senior Vice President of Auven Therapeutics, a healthcare private equity fund. Mr. Doshi formerly worked at Catalent Pharma Solutions in corporate development and operations, and he was a member of Merrill Lynch's Investment Banking Group. Mr. Doshi worked at Eli Lilly and Sapient Corporation before earning his MBA. Mr. Doshi holds a BA from Rutgers University and an MBA from the University of Pennsylvania's Wharton School. Mr. Doshi is an Aspen Institute Fellow.